$ZIOP ZIOPHARM ONCOLOGY INC Insider Trading Week 52/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ZIOPHARM ONCOLOGY INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ZIOPHARM ONCOLOGY INC in week 52/2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 02 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | WEISER MICHAEL | Director | Option Exercise | A | 5.07 | 25,000 | 126,750 | 25,000 | |
Jan 02 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | WEISER MICHAEL | Director | Payment of Exercise | F | 5.07 | 2,047 | 10,378 | 166,934 | 169 K to 166.9 K (-1.21 %) |
Jan 02 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | WEISER MICHAEL | Director | Payment of Exercise | F | 5.03 | 2,051 | 10,317 | 168,981 | 171 K to 169 K (-1.20 %) |
Jan 02 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | MCINERNEY TIMOTHY | Director | Payment of Exercise | F | 5.07 | 8,633 | 43,769 | 372,120 | 380.8 K to 372.1 K (-2.27 %) |
Jan 02 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | MCINERNEY TIMOTHY | Director | Grant | A | 0.00 | 16,707 | 0 | 380,753 | 364 K to 380.8 K (+4.59 %) |
Jan 02 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Option Exercise | A | 5.07 | 350,000 | 1,774,500 | 350,000 | |
Jan 02 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Payment of Exercise | F | 5.03 | 34,261 | 172,333 | 744,145 | 778.4 K to 744.1 K (-4.40 %) |
Jan 02 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | Lafond Kevin G | Vice Pres., Treasur ... | Option Exercise | A | 5.07 | 75,000 | 380,250 | 75,000 | |
Jan 02 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | Lafond Kevin G | Vice Pres., Treasur ... | Payment of Exercise | F | 5.03 | 4,690 | 23,591 | 26,666 | 31.4 K to 26.7 K (-14.96 %) |
Jan 02 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | BRENNAN MURRAY | Director | Option Exercise | A | 5.07 | 25,000 | 126,750 | 25,000 | |
Jan 02 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | Fowler Wyche | Director | Payment of Exercise | F | 5.07 | 9,866 | 50,021 | 113,366 | 123.2 K to 113.4 K (-8.01 %) |
Jan 02 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | Fowler Wyche | Director | Grant | A | 0.00 | 16,707 | 0 | 123,232 | 106.5 K to 123.2 K (+15.68 %) |
Jan 02 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Grant | A | 0.00 | 16,707 | 0 | 301,124 | 284.4 K to 301.1 K (+5.87 %) |
Jan 02 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Payment of Exercise | F | 5.07 | 6,167 | 31,267 | 284,417 | 290.6 K to 284.4 K (-2.12 %) |
Jan 02 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Payment of Exercise | F | 5.03 | 1,465 | 7,369 | 290,584 | 292 K to 290.6 K (-0.50 %) |
Jan 02 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | BELBEL CAESAR J | EVP, CLO, and Secre ... | Option Exercise | A | 5.07 | 175,000 | 887,250 | 175,000 | |
Jan 02 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | BELBEL CAESAR J | EVP, CLO, and Secre ... | Payment of Exercise | F | 5.03 | 7,192 | 36,176 | 23,802 | 31 K to 23.8 K (-23.20 %) |